751 related articles for article (PubMed ID: 25168729)
1. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
[TBL] [Abstract][Full Text] [Related]
2. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
4. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.
Fabelo N; Martín V; Marín R; Moreno D; Ferrer I; Díaz M
Neurobiol Aging; 2014 Aug; 35(8):1801-12. PubMed ID: 24613671
[TBL] [Abstract][Full Text] [Related]
5. Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity.
Herrera JL; Fernandez C; Diaz M; Cury D; Marin R
Steroids; 2011 Aug; 76(9):840-4. PubMed ID: 21354436
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer's disease transgenic mice: an insight into the pathogenic effects of amyloid-β.
Cuadrado-Tejedor M; Vilariño M; Cabodevilla F; Del Río J; Frechilla D; Pérez-Mediavilla A
J Alzheimers Dis; 2011; 23(2):195-206. PubMed ID: 20930307
[TBL] [Abstract][Full Text] [Related]
7. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
8. Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1/AβPP interaction in early stages of Alzheimer's disease.
Díaz M; Fabelo N; Martín V; Ferrer I; Gómez T; Marín R
J Alzheimers Dis; 2015; 43(4):1185-98. PubMed ID: 25147112
[TBL] [Abstract][Full Text] [Related]
9. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease.
Ferrer I
J Bioenerg Biomembr; 2009 Oct; 41(5):425-31. PubMed ID: 19798558
[TBL] [Abstract][Full Text] [Related]
10. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
[TBL] [Abstract][Full Text] [Related]
11. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.
Kawarabayashi T; Shoji M; Younkin LH; Wen-Lang L; Dickson DW; Murakami T; Matsubara E; Abe K; Ashe KH; Younkin SG
J Neurosci; 2004 Apr; 24(15):3801-9. PubMed ID: 15084661
[TBL] [Abstract][Full Text] [Related]
12. Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer's disease.
Herrera JL; Diaz M; Hernández-Fernaud JR; Salido E; Alonso R; Fernández C; Morales A; Marin R
J Neurochem; 2011 Mar; 116(5):820-7. PubMed ID: 21214547
[TBL] [Abstract][Full Text] [Related]
13. RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity.
Manczak M; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2368-78. PubMed ID: 24063855
[TBL] [Abstract][Full Text] [Related]
14. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
[TBL] [Abstract][Full Text] [Related]
15. Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Reddy PH
Biochim Biophys Acta; 2013 Jan; 1832(1):67-75. PubMed ID: 22995655
[TBL] [Abstract][Full Text] [Related]
16. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
[TBL] [Abstract][Full Text] [Related]
17. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells.
Oda A; Tamaoka A; Araki W
J Neurosci Res; 2010 Apr; 88(5):1137-45. PubMed ID: 19885829
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
[TBL] [Abstract][Full Text] [Related]
20. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease.
Drolle E; Hane F; Lee B; Leonenko Z
Drug Metab Rev; 2014 May; 46(2):207-23. PubMed ID: 24495298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]